QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.102.048520v1 306/1/371    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rousselle, C. Articles by Temsamani, J. Search for Related Content PubMed PubMed Citation Articles by Rousselle, C. Articles by Temsamani, J.

NEUROPHARMACOLOGY

Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy

Synt:em, Parc Scientifique Georges Besse, Nîmes, France (C.R., P.C., M.S., S.G.B., A.R.R., J.T.); Department of Molecular Neuropharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York (Y.K., G.W.P.); Institut National de la Santé et de la Recherche Médicale U26, Hôpital Fernand Widal, Paris, France (J.-M.S.)

The blood-brain barrier restricts the passage of substances into the brain. Neuropeptides, such as enkephalins, cannot be delivered into the brain when given systemically because of this barrier. Therefore, there is a need to develop efficient transport systems to deliver these drugs to the brain. Recently, we have demonstrated that conjugation of doxorubicin or penicillin to peptide vectors significantly enhances their brain uptake. In this study, we have conjugated the enkephalin analog dalargin with two different peptide vectors, SynB1 and SynB3, to improve its brain delivery and its pharmacological effect. We show by in situ brain perfusion that vectorization markedly enhances the brain uptake of dalargin. We also show using the hot-plate model that this enhancement in brain uptake results in a significant improvement in the observed antinociceptive effect of dalargin. These results support the usefulness of peptide-mediated strategies for improving the availability and efficacy of central nervous system drugs.

Address correspondence to: Jamal Temsamani, Synt:em, Parc Scientifique Georges BESSE, 30000 Nimes, France. E-mail: jtemsamani{at}syntem.com

This article has been cited by other articles:

				F.-Q. Li, G. D. Sempowski, S. E. McKenna, D. T. Laskowitz, C. A. Colton, and M. P. Vitek Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 956 - 965. [Abstract] [Full Text] [PDF]

				J. Temsamani, C. Bonnafous, C. Rousselle, Y. Fraisse, P. Clair, L.-A. Granier, A. R. Rees, M. Kaczorek, and J.-M. Scherrmann Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 712 - 719. [Abstract] [Full Text] [PDF]